In her new leadership role, Chiappinelli will build cancer research programs while continuing her work on how ancient viral DNA can trigger anti-tumor immune responses.
The award recognizes Lochner’s promise as an emerging scientist while supporting research aimed at improving immune-based approaches to clearing latent HIV infection.
Microbiology and immunology doctoral candidate Tommy DeStefanis received an NIAID F31 award to investigate antibody strategies that could help prevent HIV resistance and advance cure research.
Tucker L.C. Pyle, MD, PhD, and Luis R. Rodriguez, PhD, will advance innovative cancer research projects exploring early detection of germ cell tumors and the origins of lung squamous cell carcinoma.
Sally Feng, a student in the Integrated Biomedical Sciences (IBS) PhD program at GW’s School of Medicine and Health Sciences (SMHS), recently earned a prestigious predoctoral fellowship award from the National Institutes of Health (NIH).
The GW Vaccine Research Unit (VRU) is currently experiencing an active season, with six diverse clinical trials open for enrollment simultaneously. From tackling seasonal respiratory viruses to investigating treatments for neglected tropical diseases, the VRU operates at the forefront of global public health.
